Hyer Daniel E, Sheybani Arshin, Jacobson Geraldine M, Kim Yusung
Department of Radiation Oncology, University of Iowa, Iowa City, IA, USA.
Brachytherapy. 2012 Nov-Dec;11(6):515-20. doi: 10.1016/j.brachy.2012.01.011. Epub 2012 Mar 3.
To evaluate the dosimetric impact of heterogeneity corrections on both conventional and volume-optimized high-dose-rate (HDR) ¹⁹²Ir brachytherapy tandem-and-ovoid treatment plans.
Both conventional and volume-optimized treatment plans were retrospectively created using eight unique CT data sets. In the volume-optimized plans, the clinical target volume (CTV) and organs-at-risk (rectum, bladder, and sigmoid) were contoured on the CT data sets by a single physician. For each plan, dose calculations representing homogeneous water medium were performed using the Task Group (TG-43) formalism and dose calculations with heterogeneity corrections were performed using a commercially available treatment planning system.
For the conventional plans, the change in dose between TG-43 and heterogeneity-corrected calculations was assessed for the following points: Point-A (left and right) and International Commission on Radiation Units and Measurements (ICRU) 38 defined rectum and bladder points. It was found that the dose to the ICRU bladder decreased the most (-2.2±0.9%), whereas ICRU rectum (-1.7±0.8%), Point-A right (-1.1±0.4%), and Point-A left (-1.0±0.3%) also showed decreases with heterogeneity-corrected calculations. For the volume-optimized plans, the change in dose between TG-43 and heterogeneity-corrected calculations was assessed for the following dose-volume histogram parameters: D(90) of the CTV and D(2cc) of the rectum, bladder, and sigmoid. It was found that D(90) of the CTV decreased by -1.9±0.7% and D(2cc) decreased by -2.6±1.4%, -1.0±0.4%, and -2.0±0.6% for the rectum, bladder and sigmoid, respectively, with heterogeneity-corrected calculations.
Heterogeneity corrections on high-dose rate plans were found to have only a small dosimetric impact over TG-43-based dose calculations for both conventional Point-A and volume-optimized plans.
评估不均匀性校正对传统及体积优化高剂量率(HDR)¹⁹²Ir后装治疗串形施源器和卵形容器治疗计划的剂量学影响。
使用八个独特的CT数据集回顾性创建传统及体积优化治疗计划。在体积优化计划中,由一名医生在CT数据集上勾勒出临床靶区(CTV)及危及器官(直肠、膀胱和乙状结肠)。对于每个计划,使用任务组(TG-43)形式主义进行代表均匀水介质的剂量计算,并使用商用治疗计划系统进行不均匀性校正的剂量计算。
对于传统计划,在以下各点评估TG-43与不均匀性校正计算之间的剂量变化:A点(左右)以及国际辐射单位与测量委员会(ICRU)38定义的直肠和膀胱点。发现ICRU膀胱的剂量下降最多(-2.2±0.9%),而ICRU直肠(-1.7±0.8%)、A点右侧(-1.1±0.4%)和A点左侧(-1.0±0.3%)在不均匀性校正计算时也显示出剂量下降。对于体积优化计划,在以下剂量体积直方图参数中评估TG-43与不均匀性校正计算之间的剂量变化:CTV的D(90)以及直肠、膀胱和乙状结肠的D(2cc)。发现不均匀性校正计算时,CTV的D(90)下降了-1.9±0.7%,直肠、膀胱和乙状结肠的D(2cc)分别下降了-2.6±1.4%、-1.0±0.4%和-2.0±0.6%。
对于传统A点和体积优化计划,发现高剂量率计划中的不均匀性校正对基于TG-43的剂量计算仅有较小的剂量学影响。